Calyxt, inc. announces its filing of registration statement on form s-4 in connection with merger with cibus global llc

Roseville, minn. and san diego , feb. 15, 2023 /prnewswire/ --  calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, and cibus, a leader in precision gene editing in agriculture, today announced that calyxt has filed a registration statement on form s-4 (the "registration statement") with the u.s. securities and exchange commission ("sec") on february 14, 2023.
CLXT Ratings Summary
CLXT Quant Ranking